Baker Avenue Asset Management, LP Vertex Pharmaceuticals Inc Transaction History

Baker Avenue Asset Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $338 - $362	1 Added 1.61%	63 $21,000
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $2,200 - $2,463	-7 Reduced 10.14%	62 $21,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $450,618 - $514,052	-1,591 Reduced 95.84%	69 $21,000
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $16,859 - $18,967	-59 Reduced 3.43%	1,660 $479,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $470,713 - $525,206	1,719 New	1,719 $498,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $463,310 - $540,051	-2,238 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$207.01 - $276.09 $731,573 - $975,702	-3,534 Reduced 61.23%	2,238 $528,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $173,075 - $205,198	677 Added 13.29%	5,772 $1.57 Million
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $74,633 - $97,909	-331 Reduced 6.1%	5,095 $1.48 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $119,062 - $147,694	-596 Reduced 9.9%	5,426 $1.29 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $282,240 - $379,079	-1,693 Reduced 21.94%	6,022 $1.32 Million
Q3 2019 Nov 15, 2019	BUY	$166.23 - $187.09 $89,597 - $100,841	539 Added 7.51%	7,715 $1.31 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $39,671 - $45,879	241 Added 3.48%	7,176 $1.32 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $1.14 Million - $1.35 Million	6,935 New	6,935 $1.28 Million

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.